Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial.

Chongjian Li,Yuejin Yang,Yaling Han,Dan Song,Jing Xu,Changdong Guan,Runlin Gao,Hector M Garcia-Garcia,Ron Waksman,Bo Xu

Clinical Therapeutics（2020）

引用 14|浏览65

暂无评分

摘要

The randomized BIOFLOW-VI trial showed that BP-SES was noninferior to DP-EES with regard to the primary end point of 9-month in-stent LLL in a Chinese population. ClinicalTrials.gov Identifier: NCT02870985.

查看译文

关键词

coronary artery stenosis,drug-eluting stent,late lumen loss,percutaneous coronary intervention

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要